Book Online Tickets for The Regulation of in-house IVDs and accr, Palo Alto.  Attend this webinar to understand the definitions of in-house IVDs, the regulatory requirements including classification & essential principles, the NATA requirements related to how and when IVDs can be used as a research or diagnostic tool

The Regulation of in-house IVDs and accreditation of laboratory users in Australia

 

  • One Dial-in One Attendee

    Sale Date Ended

    USD 229
    Sold Out
  • Group-Max 10 Attendees-Location

    Sale Date Ended

    USD 599
    Sold Out
  • 1x Person - Unlimited viewing for 6 Months

    Sale Date Ended

    USD 299
    Sold Out
  • One CD-USB is for usage in one location only

    Sale Date Ended

    USD 399
    Sold Out
  • Live + Recorded Version

    Sale Date Ended

    USD 399
    Sold Out
  • Live + Training CD-USB

    Sale Date Ended

    USD 499
    Sold Out

Invite friends

Contact Us

Page Views : 1

About The Event

 Attend this webinar to understand the definitions of in-house IVDs, the regulatory requirements including classification & essential principles, the NATA requirements related to how and when IVDs can be used as a research or diagnostic tool and the current laboratory supervision requirements for the ability to perform and report on in house IVDs.

Why Should You Attend:

'In-house' IVDs are pathology tests that have been developed (or modified) within a laboratory (or laboratory network) to carry out testing on human samples, where the results are intended to assist in clinical diagnosis or be used in making decisions concerning clinical management.

Laboratories, the Therapeutic Goods Administration (TGA) and the National Association of Testing Authorities (NATA) are involved in ensuring the regulatory requirements of in-house IVDs are met. This seminar explains how laboratories that manufacture in-house IVDs can meet these requirements.

Learning Objectives:

  1. To understand the definitions of in-house IVDs
  2. To understand the regulatory requirements (including classification and Essential Principles) specific to IVDs
  3. To understand the laboratory accreditation (NATA) requirements related to how and when IVDs can be used as a research or diagnostic tool
  4. To understand current laboratory supervision requirements for ability to perform and report on in house IVDs

Areas Covered in the Webinar:

  1. The definitions of in-house IVDs
  2. The regulatory requirements (including classification and Essential Principles) specific to IVDs
  3. Laboratory accreditation (NATA) requirements related to how and when IVDs can be used as a research or diagnostic tool
  4. Current laboratory supervision requirements for ability to perform and report on in house IVDs
  5. Conformity assessment pathways
  6. TGA auditing requirements
  7. Genetic tests as in-house IVD
  8. Regulation of software as part of in house IVDs

Who Will Benefit:

  • Manufacturers of in-house IVDs
  • Regulatory associates/managers/directors of start- up companies or large corporations.
  • Pathology scientists or laboratory managers/directors

Instructor Profile:

Paul Cohen

Paul Cohen
Founder and Principal Consultant, Paul Cohen Consulting

Paul has greater than 26 years experience in the diagnostics, biotechnology, medical device and bio-pharmaceutical industry. His expertise spans clinical research, regulatory affairs, pharmacovigilance, training, quality management and process re-engineering for large pharmaceutical companies, biotech and start-up ventures.

He has worked for large pharma companies including Wyeth, Merck Sharp and Dohme, Novo Nordisk and Janssen-Cilag; start up ventures: including Sanofi Pasteur and IBAH (the CRO now known as Omnicare) and Columna. He has managed in excess of 20 Phase I-IV clinical and health outcome projects, both locally and globally.

His clinical research therapeutic area expertise includes vaccines and biological, anti-infectives, transplantation, antidepressants, rheumatology, oncology, diabetes, respiratory and orthopaedics.

He is the Principal Consultant and Director of his own boutique-consulting practice (since 2000) in clinical research, regulatory, quality and project management. He has assisted many Australian start-up companies with their clinical research, regulatory and quality strategies and taken then from concept, through clinical phases to regulatory approval and quality certification.

Paul has regulatory and compliance expertise in ICH GCP, ISO 14155, ISO 9001, ISO 13485, ISO 17025 (GLP) and GMP.

He holds an ARCS Certified Fellowship in Clinical Research and is a member of ARCS, AIMS, ASM, RAPS and a Subject Matter Expert for the World Medical Device Organisation.

He is actively involved as a mentor to PhD students as part of the IMNIS (Industry Mentoring Network in STEM) partnering with MTP Connect for the past 3 years.

He helped develop the (MHTI) Master of Health Technology Innovation post-graduate course at Sydney University/Charles Perkins Centre and lectures on regulatory/quality topics each year.

Paul is also completing a Cert IV in life and business coaching.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

More Events From Same Organizer

Venue Map